AKYÜZLÜ, D. Et Al. 2023. OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.100 .

AKYÜZLÜ, D., Ozkan-Kotiloglu, S., Danisman, M., BAL, C., Ogur, B., & Ispir, G. Z., (2023). OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.100.

AKYÜZLÜ, DİLEK Et Al. "OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder," ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.100, 2023

AKYÜZLÜ, DİLEK Et Al. "OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder." ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.100, 2023

AKYÜZLÜ, D. Et Al. (2023) . "OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder." ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.100.

@article{article, author={DİLEK AKYÜZLÜ Et Al. }, title={OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder}, journal={ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY}, year=2023}